21 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
to oversee particular projects or activities (e.g., development and/or manufacturing). Each Subcommittee will consist of a mutually agreed number
424B5
0iayb86hzmkf17 cn2f
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
2drh7p4du g0
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
umf7h28
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm
6-K
EX-4.41
dgw20qt7 4o02
9 Aug 06
Adherex Reports Second Quarter 2006 Financial Results
12:00am